US Stock MarketDetailed Quotes

MRNS Marinus Pharmaceuticals

Watchlist
  • 1.430
  • +0.040+2.88%
Close Jul 19 16:00 ET
  • 1.439
  • +0.009+0.64%
Post 19:38 ET
78.56MMarket Cap-541P/E (TTM)

Marinus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Marinus Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 8, 2024

Revenue(YoY)

7.68M

-26.02%
EPS(YoY)

-0.68

-1.49%
Analyst Rating

Buy

Jul 18, 2024

Marinus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 10.231M--
--2024/Q2-- / 9.507M--
May 8, 20242024/Q17.679M / 9.089M--
Mar 5, 20242023/Q47.190M / 8.139M--
Nov 7, 20232023/Q37.338M / 6.315M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 10.231M--
--2024/Q2-- / 9.507M--
May 8, 20242024/Q17.679M / 9.089M--
Mar 5, 20242023/Q47.190M / 8.139M--
Nov 7, 20232023/Q37.338M / 6.315M--

Unlock Free Earnings Estimates

Marinus Pharmaceuticals Earnings Reports

  • Marinus Pharmaceuticals | 10-Q: Quarterly report

    May 8 07:13 ET

  • Marinus Pharmaceuticals | 10-K: Annual report

    Mar 5 16:19 ET

  • Marinus Pharmaceuticals: Q3 2023 Earnings Report

    Nov 7, 2023 07:31 ET

  • Marinus Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 07:55 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 18, 2024

    Buy

    • Buy

      62.50%

    • Hold

      37.50%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg